GEM OS1: Pilot trial data

Interim data from a Canadian pilot trial of GEM OS1 in 29 evaluable patients showed

Read the full 154 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE